Chongqing Zhifei Biological Products
Chongqing Zhifei Biological Products Co Ltd is a Chinese biopharmaceutical enterprise manufacturing and distributing human vaccines and biological products. The company manufactures self-developed vaccines including tuberculosis, meningitis, and rabies vaccines, alongside operating as the exclusive Chinese distributor for Merck's HPV and rotavirus vaccines. Principal revenues derive from product sales of commercial human vaccines directly to provincial and local centers for disease control and prevention (CDCs) across China. Core end markets encompass pediatric patients, adolescent health programs, adult vaccination clinics, and public health agencies in Mainland China. Chongqing Zhifei Biological Products holds a market-leading position in China's human vaccine and biological distribution sector. The company is headquartered in Chongqing, China, and its common shares trade on the ChiNext board of the Shenzhen Stock Exchange.
3 of the funds FundTelligence covers report a position in Chongqing Zhifei Biological Products.
- Legal name
- Chongqing Zhifei Biological Products Co Ltd
- Sector
- Health Care
- Country
- China
- Funds holding it
- 3
Funds holding Chongqing Zhifei Biological Products
- Handelsbanken Global Index Criteria — Handelsbanken · 0.01 % (full portfolio disclosed, September 2026)
- Handelsbanken Emerging Markets Index — Handelsbanken · 0.01 % (full portfolio disclosed, September 2026)
- KLP AksjeFremvoksende Markeder Indeks — KLP · 0.0 % (full portfolio disclosed, June 2026)